Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.

作者: K Miyamoto , N Seki , R Matsushita , M Yonemori , H Yoshino

DOI: 10.1038/BJC.2016.179

关键词:

摘要: Previous studies have revealed that miR-26a-5p and miR-26b-5p act as tumour suppressors in various types of cancer tissues. Here, we aimed to investigate the functional roles these miRNAs identify their regulatory targets bladder (BC). We performed assays BC cells using transfection mature microRNAs (miRNAs). In silico luciferase reporter analyses were applied target genes miRNAs. The overall survival (OS) patients with was evaluated by Kaplan–Meier method. significantly downregulated Restoration inhibited cell migration invasion BC. gene encoding procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a collagen crosslinking enzyme, directly regulated miR-26b-5p. analysis high PLOD2 expression had shorter OS compared those low (P=0.0153). PLOD2, which is associated stiffness extracellular matrix, may be good prognostic marker

参考文章(34)
Georgina N. Masoud, Wei Li, HIF-1α pathway: role, regulation and intervention for cancer therapy Acta Pharmaceutica Sinica B. ,vol. 5, pp. 378- 389 ,(2015) , 10.1016/J.APSB.2015.05.007
MAYUKO KATO, YUSUKE GOTO, RYOSUKE MATSUSHITA, AKIRA KUROZUMI, ICHIRO FUKUMOTO, RIKA NISHIKAWA, SHINICHISA KAMOTO, HIDEKI ENOKIDA, MASAYUKI NAKAGAWA, TOMOHIKO ICHIKAWA, NAOHIKO SEKI, MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer International Journal of Oncology. ,vol. 47, pp. 710- 718 ,(2015) , 10.3892/IJO.2015.3043
Leslie H Sobin, Carolyn C. Compton, TNM seventh edition: What's new, what's changed Cancer. ,vol. 116, pp. 5336- 5339 ,(2010) , 10.1002/CNCR.25537
R Matsushita, N Seki, T Chiyomaru, S Inoguchi, T Ishihara, Y Goto, R Nishikawa, H Mataki, S Tatarano, T Itesako, M Nakagawa, H Enokida, Tumour-suppressive microRNA-144-5p directly targets CCNE1 / 2 as potential prognostic markers in bladder cancer British Journal of Cancer. ,vol. 113, pp. 282- 289 ,(2015) , 10.1038/BJC.2015.195
Akira Kurozumi, Yusuke Goto, Ryosuke Matsushita, Ichiro Fukumoto, Mayuko Kato, Rika Nishikawa, Shinichi Sakamoto, Hideki Enokida, Masayuki Nakagawa, Tomohiko Ichikawa, Naohiko Seki, Tumor‐suppressive microRNA‐223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer Cancer Science. ,vol. 107, pp. 84- 94 ,(2016) , 10.1111/CAS.12842
T Kinoshita, N Nohata, T Hanazawa, N Kikkawa, N Yamamoto, H Yoshino, T Itesako, H Enokida, M Nakagawa, Y Okamoto, N Seki, Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. British Journal of Cancer. ,vol. 109, pp. 2636- 2645 ,(2013) , 10.1038/BJC.2013.607
HANYU YOU, HUAYUE LIN, ZHONGYING ZHANG, CKS2 in human cancers: Clinical roles and current perspectives (Review) Molecular and Clinical Oncology. ,vol. 3, pp. 459- 463 ,(2015) , 10.3892/MCO.2015.501
Takahiro Ichimi, Hideki Enokida, Yasushi Okuno, Ryo Kunimoto, Takeshi Chiyomaru, Ken Kawamoto, Kazuya Kawahara, Kazuki Toki, Kazumori Kawakami, Kenryu Nishiyama, Gozoh Tsujimoto, Masayuki Nakagawa, Naohiko Seki, Identification of novel microRNA targets based on microRNA signatures in bladder cancer. International Journal of Cancer. ,vol. 125, pp. 345- 352 ,(2009) , 10.1002/IJC.24390
H Yoshino, T Chiyomaru, H Enokida, K Kawakami, S Tatarano, K Nishiyama, N Nohata, N Seki, M Nakagawa, The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer British Journal of Cancer. ,vol. 104, pp. 808- 818 ,(2011) , 10.1038/BJC.2011.23